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Introduction. Hirsutism is the exaggerated increase of terminal hair in women, developing a 
male model. Hirsutism is an important medical problem, not just a cosmetic defect, which 
currently affects about 5-15% of women. The researchers have shown that the impact of 
hirsutism symptoms on a woman's quality of life can be profound and can lead to psychological 
stress that threatens her feminine identity. Despite a large number of published works, some 
aspects of hirsutism are still controversial or underestimated. The treatment of hirsutism often 
requires a multidisciplinary approach and a variety of physical or pharmacological modalities 
can be used with the combination of 2 or more drugs in combination with esthetic treatment, 
depending on the involved etiopathogenetic mechanism. 
Aim of the study. Evaluation of the molecular-genetic bases of hirsutism, the study of clinical 
polymorphism and the management of women with hirsutism. 
Materials and methods. Online databases, meta-analyzes, scientific papers in theoretical and 
practical medicine were used. 
Results. Following the analyses of the scientific papers we highlighted the main etiological 
factors of hirsutism: ovarian (93% PCOS, <1% androgendependent tumors, <1% luteoma); 
adrenals (<1% CAH, <1% Cushing syndrome, <1% androgen secretory tumors, 1% acromegaly) 
and other external factors (<1% iatrogenic, <1% androgenic drugs). The genetic approach has 
noted the involvement in the development of hirsutism of mutations in 5 major genes encoding 
important enzymes in androgen metabolism: 21-hydroxylase, P450 cytochrome oxidoreductase, 
aromatase, 11-beta-hydroxylase, 5 alpha reductase. The diagnosis of hirsutism is based on a 
detailed anamnesis, the objective exam using the Ferriman-Galway scale, seric markers, 
additional genetic and paraclinical tests. Ovarian suppression of androgens secretion with oral 
contraceptives is widely used in these women, but its efficacy is limited. One of the most 
effective medical therapies for hirsutism is medication with anti-androgens (spironolactone, 
finasteride, flutamide, etc.)  
Conclusions. Hirsutism is a current medical problem that affects women's quality of life. PCOS 
(polycystic ovary syndrome) is the most common cause of hirsutism. The management of a 
woman with hirsutism requires a multidisciplinary approach - family doctor, endocrinologist, 
gynecologist, dermatologist. The treatment is indicated according to the ethiopathological, 
individualized mechanism, treatment strategies can be included with the combination of 2 or 
more drugs. Aesthetic and maintenance treatment is not excluded.  
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Introduction. Female infertility is defined as the inability to conceive after one year of regular 
unprotected intercourse for women younger than 35 years and within 6 months for women after 
35 years. One in seven couples experiences infertility or subfertility, and in 40% of cases it is 
because of women. Clinically, female infertility is a highly heterogeneous pathology with a 
complex etiology that includes environmental and genetic factors. It is difficult to assess 
accurately the overall magnitude of the contribution of the genetics to female infertility as most, 
if not all, conditions are likely to have a genetic component. Nethertheless, a significant number 
of infertility phenotypes have been associated with specific genetic anomalies.  
Aim of the study. - This review aims to summarize current research on genetic diagnosis and 
genetic causes of female infertility.  
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Material and methods. It has been used online databases and scientific articles that contain 
studies of female infertility.  
Results. All genetic defects can be divided into the following categories: chromosome 
aberrations, DNA copy number variants (micro deletions and duplications), single-gene 
disorders, complex conditions and epigenetic disorders. Chromosome abnormalities account for 
almost 60% of all spontaneous abortions, and the most common type, trisomy, is closely 
associated with advanced maternal age. There are 2 forms of female infertility: primary and 
secondary. Primary female infertility includes premature ovarian failure, polycystic ovary 
syndrome, endometriosis, and leiomyoma. Secondary infertility arises due to systemic or 
syndromic genetic defects, including developmental, endocrine, and metabolic defects. Genetic 
syndromes that manifest female infertility are fragile X syndrome, Noonan syndrome, sickle cell 
anemia, etc. Other notable conditions include disorders of sex development (SRY), reproductive 
dysgenesis disorders hypogonadotropic hypogonadism and Kallmann syndrome (KAl1, GNRH1, 
LEP) , and ambiguous genitalia an androgen insensitivity (AR). Endocrine defects comprise 
disruption of steroid synthesis and metabolism, and are caused by CYP17 and CYP19 mutation. 
Also, various metabolic defects (e.g., galactosemia ) and mutation in mitochondrial energy 
pathway (mitochondrial DNA genes) cause toxic effects and lead to secondary female infertility. 
Conclusions. The genetics of infertility is very complex and is dependent on different factors. 
Clearly the hope is that a greater understanding of the genetic control of infertility will bring 
low-risk treatment regimens that are effective and easy to administer. 
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Introduction. Intellectual disability (ID) is a neurodevelopment disease characterized by 
intellectual and adaptive impairment, defined by intelligence quotient (IQ) under 70 and can be 
affirmed after the age of 6. Until this age, the retard is named development delay (DD). This 
condition is found in 2-3% of individuals in general population, and 50% of these cases are 
associated with other clinical features, like pediatric obesity. The genomic study using 
microarray chromosomal techniques revealed in about 20% of intellectual disability patients a 
genetic cause of copy number variants (CNVs) type, duplication or deletion, but there is a lack of 
data about CNVs found in patients with ID/DD associated with obesity.  
Aim of the study. To find CNVs that could be responsible for the ID/DD associated with obesity 
phenotype, in 36 Romanian pediatric patients, recruited from the Clinical Emergency Hospital 
for Children, Cluj-Napoca, Romania.  
Materials and methods. We used SNP array technique, Infinum OmniExpress 24V1.2 in order 
to detect CNVs. Data analysis was made using Genome Studio, and the interpretation of the data 
was performed using UCSC data base (Decipher, ClinVar, Omim and Gene Reviews).  
Results. We found relevant genetic alterations in 15 patients (42%). Several of them presented 
deletions and duplications that were described before in international databases, but potential 
pathogen CNVs not described before were also detected. Therefore, we describe a deletion inside 
KANSL1, the gene responsive for Koolen-De Vries syndrome, a small deletion in OTC gene, a 
8p23.1 duplication in BLK gene and also a patient that presented two uniparental disomies, for 
chromosome 7 and 13.  
